Cannabis Global Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cannabis Global Inc. inventory turnover ratio, the Cannabis Global Inc.'s ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 11.85 in the third quarter 2022, a new company high. Average processing period, for Cannabis Global's inventories remained unchanged at 31 days, in the May 31 2022 quarter.

Within Healthcare sector 24 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 320 in the second quarter 2022, to 325.

CBGL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cannabis Global Inc. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CBGL Inventory Turnover Ratio	(May 31 2022) III. Quarter	(Feb 28 2022) II. Quarter	(Nov 30 2021) I. Quarter	(Aug 31 2021) IV. Quarter	(May 31 2021) III. Quarter
Y / Y Inventory Growth	8.39 %	8.54 %	326.65 %	150.98 %	366.83 %
Y / Y Cost of Sales Growth	7.01 %	11442.1 %	34974.46 %	13954.15 %	4245.96 %
Inventory Turnover Ratio (TTM)	11.85	11.83	8.55	9.03	5.78
CBGL's Total Ranking	# 325	# 320	# 322	# 12	#
Average inventory processing period	31	31	43	40	63
Seq. Inventory Growth	1.05 %	-39.55 %	71.1 %	3.72 %	1.19 %
Seq. Cost of Sales Growth	1.68 %	68.41 %	-32.87 %	-6.9 %	10866.48 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 1
Healthcare Sector	# 25
Overall Market	# 325

Inventory Turnover Ratio Statistics
High	Average	Low
11.85	5.48	0.32
(May 31 2022)		(Feb 28 2021)

CBGL Company Profile >> Back to CBGL Efficiency Comparisons >> Compare CBGL Inventory Turnover Ratio to its Competitors

Financial Statements
Cannabis Global's Inventories	$ 0 Millions	Visit CBGL's Balance sheet
Cannabis Global's Cost of Revenues TTM	$ 3 Millions	Visit CBGL's Income Statement
What are CBGL's Sales?		Visit CBGL's Sales by Segment

Other Inventory Turnover Ratios
Cannabis Global's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CBGL's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CBGL's Competitors
Inventory Turnover Ratio for CBGL's Suppliers
Inventory Turnover Ratio for CBGL's Customers

You may also want to know
CBGL's Sales Growth Rates	CBGL's Pe Price to earnings ratio	CBGL's Receivables Turnover Ratio	CBGL's Stock Quote
CBGL's Net Income Growth Rates	CBGL's Ps Price to Sales ratio	CBGL's Sales per Employee	CBGL's Asset Turnover Ratio
CBGL's Net Margin	CBGL's Pb Price to Book ratio	CBGL's Financial Strength Ratios	CBGL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending May 31 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending May 31 2022	Inventories at quarter ending May 31 2022
Quest Diagnostics Inc	33.35	$ 6,645.000 Millions	$ 199 Millions
Intelgenx Technologies Corp	27.84	$ 2.109 Millions	$ 0 Millions
Labcorp Holdings Inc	25.10	$ 10,599.100 Millions	$ 422 Millions
Vaso Corporation	22.06	$ 32.403 Millions	$ 1 Millions
Aspira Women s Health inc	21.92	$ 3.786 Millions	$ 0 Millions
Adapthealth Corp	21.90	$ 2,328.640 Millions	$ 106 Millions
Vanda Pharmaceuticals Inc	21.01	$ 24.757 Millions	$ 1 Millions
Biocept Inc	19.77	$ 40.627 Millions	$ 2 Millions
Rennova Health Inc	19.60	$ 5.372 Millions	$ 0 Millions
Viemed Healthcare Inc	18.64	$ 48.636 Millions	$ 3 Millions
Dermtech Inc	16.48	$ 12.765 Millions	$ 1 Millions
Harmony Biosciences Holdings inc	14.65	$ 66.059 Millions	$ 5 Millions
Option Care Health Inc	14.03	$ 2,882.734 Millions	$ 205 Millions
Rockwell Medical inc	13.94	$ 65.529 Millions	$ 5 Millions
Natera Inc	13.68	$ 377.722 Millions	$ 28 Millions
Cannabis Global Inc.	11.85	$ 2.684 Millions	$ 0 Millions
Myriad Genetics Inc	11.79	$ 191.300 Millions	$ 16 Millions
Precipio inc	11.36	$ 6.838 Millions	$ 1 Millions
Infusystem Holdings Inc	11.23	$ 46.051 Millions	$ 4 Millions
Lifemd Inc	10.55	$ 19.532 Millions	$ 2 Millions
Evolus Inc	10.49	$ 56.351 Millions	$ 5 Millions
23andme Holding Co	10.47	$ 149.429 Millions	$ 14 Millions
Irhythm Holdings Inc	10.38	$ 122.230 Millions	$ 12 Millions
Clene Inc	10.27	$ 0.583 Millions	$ 0 Millions
Sunlink Health Systems Inc	10.22	$ 19.107 Millions	$ 2 Millions
Cryo cell International Inc	10.19	$ 9.060 Millions	$ 1 Millions
Invitae Corporation	9.99	$ 391.303 Millions	$ 39 Millions
Prophase Labs Inc	9.91	$ 55.260 Millions	$ 6 Millions
Sotera Health Company	9.76	$ 431.996 Millions	$ 44 Millions
Opko Health Inc	9.30	$ 887.974 Millions	$ 96 Millions

Date modified: 2026-06-22T14:32:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.